Evidence map›Paper›PMID 32458356›Full record

ReviewAging clinical and experimental research2020

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.

Katie Palmer, Alessandro Monaco, Miia Kivipelto, Graziano Onder, Stefania Maggi, Jean-Pierre Michel, Rita Prieto, Georgia Sykara, Shaantanu Donde

Open access · hybridAbstract readReview
In one paragraph

Review in Aging clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 194 papers.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed
28.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 373 citations in OpenAlex.

  1. Common surgical masks and unattended blood pressure changes in treated hypertensive patients.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The relationship between healthcare access and change in health-related quality-of-life among the general population of five countries during the COVID-19 pandemic.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  20. Article

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 7 countries.

Katie PalmerOliba, Rome, Italy.
Alessandro MonacoHEC, 1, Rue de la Liberation Jouy en Josas, Paris, France. alessandro.monaco@hec.edu.ORCID http://orcid.org/0000-0002-9941-7003
Miia KivipeltoDivision of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm, Sweden.
Graziano OnderDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Stefania MaggiCNR-Neuroscience Institute, Aging Branch, Padua, Italy.
Jean-Pierre MichelDepartment of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva, Switzerland.
Rita PrietoPfizer GEP SLU, Upjohn, Madrid, Spain.
Georgia SykaraMedical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens, Greece.
Shaantanu DondeUpjohn (Division of Pfizer), Surrey, UK.
HEC Paris · FRIstituto Superiore di Sanità · ITKarolinska University Hospital · SENeuroscience Institute · ITPfizer (Spain) · ESPfizer (United Kingdom) · GBUniversità Cattolica del Sacro Cuore · ITUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.

Indexed as

Healthy AgingAgedBetacoronavirusChronic DiseaseCoronavirus InfectionsCOVID-19Delivery of Health CareDisease OutbreaksDisease ProgressionEuropeFrail ElderlyFrailtyHumansInfection ControlLonelinessNoncommunicable DiseasesChronic diseasesCoronavirusCOVID-19ElderlyFrailtyNCDSARS-coV-2

Identifiers

PMID32458356
PMCPMC7248450
OpenAlexW3030304756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.